Abstract:We discovered a novel synergistic antibacterial strategy involving the incorporation of Au(I) unit into aggregation‐induced emission (AIE)‐active photosensitizers to construct a series of multifunctional luminescent systems. The integration of gold(I) has endowed the AIE ligand with specific bacterial targeting and synergistic, high‐efficiency chemo‐phototherapy of drug‐resistant bacteria. Antimicrobial resistance (AMR) remains an urgent and formidable challenge to global public health. Developing new medicines or alternative therapies to address AMR is imperative. Herein, we rationally designed and synthesized a series of Au(I)‐based aggregation‐induced emission luminogens (AIEgens) to combat drug‐resistant bacterial infections. Through systematic screening, we identified an optimal AIEgen, called complex 5, which can rapidly discriminate between gram‐positive (G+) and gram‐negative bacteria (G−) bacteria, and exert robust and broad‐spectrum antimicrobial potency against diverse drug‐resistant bacterial strains, including those intractable to treat in clinic. Furthermore, extensive testing against a variety of clinical drug‐resistant isolates, coupled with the successful treatment of methicillin‐resistant Staphylococcus aureus‐infected skin wounds unequivocally validates the high efficiency and broad‐spectrum activity of complex 5. Therefore, complex 5 emerges as a promising candidate for combating drug‐resistant bacterial infections in clinic, and this work provides inspiration for developing new solutions to address the escalating global challenge of AMR.

Molecular docking-aided AIEgen design: concept, synthesis and applications

Exploration of Biocompatible AIEgens from Natural Resources

Dipole‐Dipole and Anion‐π+ Interaction Manipulation Synergistically Enhance Intrinsic Antibacterial Activities of AIEgens

Structure-oriented design strategy to construct NIR AIEgens to selectively combat gram (+) multidrug-resistant bacteria in vivo

Cationic Tricyclic AIEgens for Concomitant Bacterial Discrimination and Inhibition

AIEgen-Based Nanomaterials for Bacterial Imaging and Antimicrobial Applications: Recent Advances and Perspectives

Elaborately engineered Au(I)‐based AIEgens: Robust and broad‐spectrum elimination abilities toward drug‐resistant bacteria

Recent advances toward emerging nanozymes with aggregation-induced emission

Application of AIE-active Molecules in Biosensing

AIEgens for microorganism‐related visualization and therapy

Synthesis of AIE-Active Materials with Their Applications for Antibacterial Activity, Specific Imaging of Mitochondrion and Image-Guided Photodynamic Therapy.

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

An AIE-Active Cyclometalated Iridium(III) Photosensitizer for Selective Discrimination, Imaging, and Synergistic Elimination of Gram-Positive Bacteria

Tricyclic 2-Aminopyridinium Derivatives with Aggregation-Induced Emission for Concomitant Bacterial Discrimination and Inhibition

An AIEgen as an Intrinsic Antibacterial Agent for Light‐Up Detection and Inactivation of Intracellular Gram‐Positive Bacteria

Phospholipid-Mimetic Aggregation-Induced Emission Luminogens for Specific Elimination of Gram-Positive and Gram-Negative Bacteria.

Efficient Killing of Multidrug-Resistant Intracellular Bacteria by AIEgens in Vivo

Aggregation-Induced Emission-Based Platforms for the Treatment of Bacteria, Fungi, and Viruses

Lipophilic AIEgens as The "Trojan" Sniper with Discrepant Efficacy in Tracking And Treatment of Mycobacterial Infection

Efficient Killing of Multidrug‐Resistant Internalized Bacteria by AIEgens In Vivo

Seeing is believing: Efficiency evaluation of multifunctional ionic-dependent AIEgens for tuberculosis